Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advances in biomarkers of major depressive disorder.

Advances in clinical chemistry - 1 Jan 2015

Huang Tiao-Lai, Lin Chin-Chuen

Abstract excerpt

Major depressive disorder (MDD) is characterized by mood, vegetative, cognitive, and even psychotic symptoms and signs that can cause substantial impairments in quality of life and functioning. Biomarkers are measurable indicators that could help diagnosing MDD or predicting treatment response. In this chapter, lipid profiles, immune/inflammation, and neurotrophic factor pathways that have long been implicated in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain-Derived Neurotrophic Factor
Share to Catechol O-Methyltransferase
Share to Cytokines

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Lipids

Share to Metabolomics

Share to Monoamine Oxidase

Share to Serotonin Plasma Membrane Transport Proteins

Source

Identifiers

PMID: 25858873
DOI: 10.1016/bs.acc.2014.11.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advances in biomarkers of major depressive disorder.PMID 25858873Read ↗

A review of new insights into existing major depressive disorder biomarkersSemantic proximity Read ↗

Novel biomarkers in major depressionSemantic proximity Read ↗

Advancing Depression Management Through Biomarker Discovery with a Focus on Genetic and Epigenetic Aspects: A Comprehensive Study on Neurobiological, Neuroendocrine, Metabolic, and Inflammatory PathwaysSemantic proximity Read ↗

Dysregulation of brain dopamine systems in major depressive disorderSemantic proximity Read ↗

Biochemical markers subtyping major depressive disorderSemantic proximity Read ↗

Personalized medicine in major depressive disorder -- opportunities and pitfalls.Semantic proximity Read ↗

Major depressive disorder, neuroticism, suicidal behaviors, and depression severity are all associated with neurotoxic immune networks and their intricate interactions with metabolic syndromeSemantic proximity Read ↗

Major depressive disorder, neuroticism, suicidal behaviors, and depression severity are all associated with neurotoxic immune networks and their intricate interactions with metabolic syndrome.Semantic proximity Read ↗

The Metabolome-Wide Signature of Major Depressive DisorderSemantic proximity Read ↗

Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studiesSemantic proximity Read ↗

Are there meaningful biomarkers of treatment response for depression?Semantic proximity Read ↗

The Exposome of Major Depressive Disorder in an Egyptian Sample: A Pilot StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.